Pharmacotherapy for Stimulant Use Disorder

Pharmacotherapy plays a crucial role in managing stimulant use disorders by targeting the neurochemical pathways affected by substances like cocaine and methamphetamine. Current treatments focus on reducing cravings, mitigating withdrawal symptoms, and preventing relapse. Medications such as bupropion and modafinil are being explored for their ability to stabilize dopamine levels and improve cognitive function. Additionally, emerging treatments like monoclonal antibodies aim to block the stimulant’s effects directly. Behavioral therapies, including cognitive-behavioral therapy (CBT), often complement pharmacological interventions, addressing the psychological aspects of addiction. Despite promising advancements, challenges remain in achieving sustained recovery. A comprehensive approach combining medication, psychosocial support, and lifestyle modifications is essential to improve outcomes for individuals with stimulant use disorders.